Liverpool Heart and Chest Hospital, Liverpool (United Kingdom of Great Britain & Northern Ireland)
Follow
Contributor content
Presentation
Potential use of PCSK9 inhibitors in secondary prevention for patients with treated acute coronary syndrome. A study from a large UK university teaching hospital
